[HTML][HTML] new treatments for advanced differentiated thyroid cancers and potential mechanisms of drug resistance
S Hamidi, MC Hofmann, PC Iyer… - Frontiers in …, 2023 - frontiersin.org
The treatment of advanced, radioiodine refractory, differentiated thyroid cancers (RR-DTCs)
has undergone major advancements in the last decade, causing a paradigm shift in the …
has undergone major advancements in the last decade, causing a paradigm shift in the …
[HTML][HTML] new treatments for advanced differentiated thyroid cancers and potential mechanisms of drug resistance
S Hamidi, MC Hofmann, PC Iyer… - Frontiers in …, 2023 - ncbi.nlm.nih.gov
The treatment of advanced, radioiodine refractory, differentiated thyroid cancers (RR-DTCs)
has undergone major advancements in the last decade, causing a paradigm shift in the …
has undergone major advancements in the last decade, causing a paradigm shift in the …
[PDF][PDF] for advanced differentiated thyroid cancers and potential mechanisms of drug resistance
S Hamidi, MC Hofmann, PC Iyer, ME Cabanillas, MI Hu… - 2023 - core.ac.uk
Differentiated thyroid cancers (DTCs) have an excellent prognosis in most patients, with an
overall 5-year relative survival rate of 98.4% according to the SEER database (1). However …
overall 5-year relative survival rate of 98.4% according to the SEER database (1). However …
new treatments for advanced differentiated thyroid cancers and potential mechanisms of drug resistance
S Hamidi, MC Hofmann, PC Iyer… - Frontiers in …, 2023 - mdanderson.elsevierpure.com
The treatment of advanced, radioiodine refractory, differentiated thyroid cancers (RR-DTCs)
has undergone major advancements in the last decade, causing a paradigm shift in the …
has undergone major advancements in the last decade, causing a paradigm shift in the …
new treatments for advanced differentiated thyroid cancers and potential mechanisms of drug resistance
S Hamidi, MC Hofmann, PC Iyer… - Frontiers in …, 2023 - pubmed.ncbi.nlm.nih.gov
The treatment of advanced, radioiodine refractory, differentiated thyroid cancers (RR-DTCs)
has undergone major advancements in the last decade, causing a paradigm shift in the …
has undergone major advancements in the last decade, causing a paradigm shift in the …
new treatments for advanced differentiated thyroid cancers and potential mechanisms of drug resistance.
S Hamidi, MC Hofmann, PC Iyer… - Frontiers in …, 2023 - europepmc.org
The treatment of advanced, radioiodine refractory, differentiated thyroid cancers (RR-DTCs)
has undergone major advancements in the last decade, causing a paradigm shift in the …
has undergone major advancements in the last decade, causing a paradigm shift in the …